MedTech World Bay Area, California

Chris is a former C-suite executive with over 35 years of global experience in medtech. He has held top leadership roles at large multinational corporations as well as multiple board positions, and is well versed in early-stage company development. Chris is currently a Managing Partner at Tramway Ventures, a New-Mexico based VC focused on medtech, biotech, and health tech innovation investments in the southwest. Chris is based in Santa Fe, New Mexico.

Dr. Gershony is an internationally recognized interventional cardiologist and serial MedTech entrepreneur. He was the Founder of Vascular Solutions, helped lead a successful IPO in 2000, and served as the company’s Chief Medical Officer and Board member. He subsequently co-founded AngioScore which developed novel angioplasty scoring balloons and served as Chief Medical Office and Board member until its acquisition in 2014. Dr. Gershony is a Founding General Partner at BayMed Venture Partners which is based in San Francisco. He currently serves on the boards of multiple medical device companies and is a frequent speaker at investor conferences

Kristen Mittal, Co-founder & CEO of Mittal Consulting, holds biomedical engineering degrees and is RAC and PMP certified. As the Co-founder of Mittal Consulting, she guides medical device startups from concept to commercialization, specializing in regulatory strategy, submissions and working with complex medical devices which often goes through FDA DeNovo or Breakthrough pathways. Kristen partners with leading medtech incubators and universities, shaping future innovators through education and hands-on regulatory expertise.

Christian Espinosa founded Blue Goat Cyber and is a global leader in medical device cybersecurity. With 30+ years of experience, he empowers manufacturers to achieve FDA, EU MDR, and international compliance while safeguarding patient safety. A bestselling author and Ironman triathlete, Christian blends expertise and determination to tackle complex cybersecurity challenges.

Mridul is the Co-Founder of Mittal Consulting, bringing deep expertise in client relations, business development, and company strategy. With a background in product and customer facing applications, he combines cross-industry insight with a passion for entrepreneurship and marketing. A natural connector and forward-thinker, Mridul continues to elevate the firm’s presence through meaningful partnerships and market-focused innovation

Eric C. Ulchaker is Managing Partner at SSVP, a healthcare-focused investor network. He brings over a decade of startup and venture experience, including roles at Notre Dame’s Pit Road Fund and the 1842 Fund. He’s an active angel investor and graduate of Ohio State, Notre Dame, and Case Western Reserve.

Accomplished venture capital investor with a proven track record. Focusing on AI + Life Science/Healthcare. Extensive network spans across senior executives, academic leaders and syndicate investors. Before her venture capital career, Qing was a physician at Singapore General Hospital and a researcher at Broad Institute. She holds M.D. at Tsinghua University and MBA from Columbia Business School.

Jeff is a MedTech researcher, inventor, and award-winning product developer with 20+ years of experience translating technologies into market-ready solutions. He’s an exited founder, PI on NIH/DoD grants, holds 16+ patents, and board member for several companies/organizations. Jeff serves as EIR at Northeastern, Dartmouth, and MassChallenge, actively supporting early-stage companies.

Rhiya Pau is a Principal at the Million Lives Fund focused on cardiovascular devices and a Board Member at Corflow Therapeutics. She previously worked at the UK’s Development Finance Institution investing in healthcare services companies across Africa and South Asia.

Rich is a parter at Gilde, a growth stage transatlantic healthtech investor. Prior to Gilde, Rich was the Global Head of Ventures at Philips, where he was responsible for creating, launching and running the venture program.  Rich began the venture phase of his career at Mass General Brigham where he was a member of the Partners Innovation Fund.